Evaluation of somatostatin analogues for the detection and treatment of gastrinoma in a dog.

Gastrinomas in dogs are difficult to diagnose, localise and treat. In humans, somatostatin analogues have improved localisation and treatment of gastrinomas. The somatostatin analogues pentetreotide and octreotide were evaluated for the detection and treatment of gastrinoma in a dog. 111indium-pentetreotide scintigraphy revealed multiple areas of activity in the patient's mid-ventral abdomen which were consistent with masses in the pancreas and liver at laparotomy. Immunohistochemistry, electron microscopy and binding of 125I-[Tyr3]-octreotide in vitro confirmed the lesion as a gastrinoma which expressed somatostatin receptors. Octreotide at doses of 2, 4 and 8 micrograms/kg caused transient decreases in circulating gastrin. Plasma somatostatin peaked at one hour after octreotide and was still detectable at four and six hours after administration of octreotide. Combination therapy with famotidine, omeprazole, sucralfate and increasing doses of octreotide allowed patient survival for 14 months.

[1]  E. Krenning,et al.  The visualization of gastroenteropancreatic endocrine tumors. , 1993, Digestion.

[2]  J. Foekens,et al.  Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects. , 1990, British Journal of Cancer.

[3]  S. Reichlin.  Secretion of somatostatin and its physiologic function. , 1987, The Journal of laboratory and clinical medicine.

[4]  D. Venzon,et al.  Somatostatin Receptor Scintigraphy: Its Sensitivity Compared with That of Other Imaging Methods in Detecting Primary and Metastatic Gastrinomas: A Prospective Study , 1996, Annals of Internal Medicine.

[5]  E. Ellison,et al.  Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin. , 1986, American journal of surgery.

[6]  J. Charboneau,et al.  Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. , 1990, Cancer research.

[7]  E. Krenning,et al.  Somatostatin-receptor imaging in the localization of endocrine tumors. , 1990, The New England journal of medicine.

[8]  F. Jamar,et al.  Localization of gastroenteropancreatic neuroendocrine tumors with 111indium-pentetreotide scintigraphy. , 1994, Seminars in oncology.

[9]  J. Reubi,et al.  Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors. , 1987, The Journal of clinical endocrinology and metabolism.

[10]  K. Simpson,et al.  Evaluation of the long-acting somatostatin analogue octreotide in the management of insulinoma in three dogs. , 1995, Journal of Small Animal Practice.

[11]  E. Breitschwerdt,et al.  Zollinger-Ellison syndrome and myelofibrosis in a dog. , 1988, Journal of the American Veterinary Medical Association.

[12]  J. Laissue,et al.  Expression of Somatostatin Receptors in Normal, Inflamed, and Neoplastic Human Gastrointestinal Tissues , 1994, Annals of the New York Academy of Sciences.

[13]  I. Modlin,et al.  Use of an isotopic somatostatin receptor probe to image gut endocrine tumors. , 1995, Archives of surgery.

[14]  W. Melvin,et al.  Indium-111-pentetreotide scanning versus conventional imaging techniques for the localization of gastrinoma. , 1995, Surgery.

[15]  S. Orloff,et al.  Advances in the management of patients with Zollinger-Ellison syndrome. , 1995, The Surgical clinics of North America.

[16]  R. Jensen,et al.  Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study. , 1989, Gastroenterology.

[17]  J. Rehfeld,et al.  Zollinger-Ellison Syndrome in Three Dogs , 1980, Veterinary pathology.

[18]  M. R. Nicholls,et al.  Peptic ulceration in a dog associated with an islet cell carcinoma of the pancreas and an elevated plasma gastrin level. , 1976, The Journal of small animal practice.

[19]  H. Mekhjian,et al.  Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas. , 1986, Surgery.

[20]  C. Rousseaux.  Ultrastructure of a canine gastrinoma. , 1987, Journal of Comparative Pathology.

[21]  E. Krenning,et al.  Somatostatin‐receptor Scintigraphy in Gastroenteropancreatic Tumors , 1994, Annals of the New York Academy of Sciences.

[22]  T. Yamada,et al.  Mechanisms for direct inhibition of canine gastric parietal cells by somatostatin. , 1987, The Journal of biological chemistry.

[23]  P. Fabri,et al.  Characterization of the in vivo and in vitro inhibition of gastrin secretion from gastrinoma by a somatostatin analogue (SMS 201-995). , 1986, The American journal of medicine.

[24]  R. Yalow,et al.  Canine Zollinger-Ellison syndrome. , 1977, Gastroenterology.

[25]  L. Kvols,et al.  Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors. , 1993, Radiology.